Alliance Pharma (LSE:APH) PB Ratio : 0.68 (As of Apr. 29, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Alliance Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-04-29), Alliance Pharma's share price is £0.3495. Alliance Pharma's Book Value per Share for the quarter that ended in Jun. 2023 was £0.51. Hence, Alliance Pharma's PB Ratio of today is 0.68.

Good Sign:

Alliance Pharma PLC stock PB Ratio (=0.68) is close to 10-year low of 0.65

The historical rank and industry rank for Alliance Pharma's PB Ratio or its related term are showing as below:

LSE:APH' s PB Ratio Range Over the Past 10 Years
Min: 0.65 Med: 1.45 Max: 2.36
Current: 0.68

During the past 13 years, Alliance Pharma's highest PB Ratio was 2.36. The lowest was 0.65. And the median was 1.45.

LSE:APH's PB Ratio is ranked better than
88.8% of 964 companies
in the Drug Manufacturers industry
Industry Median: 1.94 vs LSE:APH: 0.68

During the past 12 months, Alliance Pharma's average Book Value Per Share Growth Rate was -6.70% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 1.00% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 3.90% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 10.20% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Alliance Pharma was 55.10% per year. The lowest was -56.00% per year. And the median was 12.00% per year.

Back to Basics: PB Ratio

Alliance Pharma PB Ratio Historical Data

The historical data trend for Alliance Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alliance Pharma PB Ratio Chart

Alliance Pharma Annual Data

Trend

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

PB Ratio

Get a 7-Day Free Trial

1.38

1.62

1.66

2.07

0.99

Alliance Pharma Semi-Annual Data
	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
PB Ratio	Get a 7-Day Free Trial															1.90	2.07	2.08	0.99	0.97

Competitive Comparison of Alliance Pharma's PB Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Alliance Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alliance Pharma's PB Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alliance Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Alliance Pharma's PB Ratio falls into.

Alliance Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Alliance Pharma's PB Ratio for today is calculated as follows:

PB Ratio	=	Share Price	/	Book Value per Share (Q: Jun. 2023)
	=	0.3495	/	0.513
	=	0.68

It can also be calculated from the numbers for the whole company:

PB Ratio

Market Cap

(Total Stockholders Equity

Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Alliance Pharma (LSE:APH) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Alliance Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Alliance Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Alliance Pharma (LSE:APH) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alliance Pharma PLC (LSE:APH) » Definitions » PB Ratio

Comparable Companies

Traded in Other Exchanges

DVL:Germany

Address

Bath Road, Avonbridge House, Chippenham, Wiltshire, GBR, SN15 2BB

Website

https://www.alliancepharmaceuticals.com

Alliance Pharma PLC is a player in the healthcare market. The company's business includes the acquisition, marketing, and distribution of consumer healthcare and pharmaceutical products. The group operates in two segments: Consumer Healthcare brands and Prescription Medicines. It generates the majority of its revenue from the Consumer Healthcare segment. Its products include Aloclair, Biodermatin, Changmin, Decapional, Effadiane, and Fazol. The company generates maximum revenue from the Kelo-cote brand. Geographically, it derives a majority of its revenue from Europe, the Middle East, and Africa (EMEA).